Earnings · China A-shares
Sichuan Biokin Pharmaceutical Co., Ltd. Class A (688506) earnings
Sichuan Biokin Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit -42.55% year on year, -33.90% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +6.65% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -42.55%
- Excl. one-offs YoY
- -33.90%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +3.66% | — |
| 3 days | +6.65% | — |
| 7 days | +6.07% | — |
| 14 days | +3.25% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +1.44%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥704.92M | -42.55% | -33.90% | +1.35% | -1.71 | -11.66% | +6.65% | — | — |
| 2026 interim report | 2026-08-27 | -¥1.64B | -46.45% | -43.58% | +9.43% | -3.97 | -28.92% | -0.87% | -14.12% | -5.19% |
| 2026 Q1 report | 2026-04-28 | -¥774.56M | -45.75% | -48.87% | +40.25% | -1.88 | -12.60% | -4.14% | -23.25% | -22.62% |
| 2025 annual report | 2026-04-28 | -¥1.05B | -128.42% | — | -56.72% | -2.61 | -24.55% | -4.14% | -23.25% | -22.62% |
| 2025 Q3 report | 2025-10-27 | -¥494.52M | -112.16% | — | -63.52% | -1.23 | -13.59% | -2.43% | +3.31% | +3.54% |
| 2025 interim report | 2025-08-20 | -¥1.12B | -123.96% | — | -96.92% | -2.79 | -33.60% | +5.98% | +19.90% | +9.85% |
| 2025 Q1 report | 2025-04-30 | -¥531.44M | -110.62% | — | -98.77% | -1.33 | -14.68% | +0.64% | +11.70% | +8.53% |
| 2024 annual report | 2025-03-29 | ¥3.71B | +575.02% | +547.31% | +936.31% | 9.25 | 184.86% | +4.22% | +12.44% | +14.00% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.